{
    "eid": "2-s2.0-85148511537",
    "title": "The role of the topical nasal decongestant oxymetazoline as a novel therapeutic option for post-acne erythema: A split-face, double-blind, randomized, placebo-controlled trial",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Dermatology",
            "@code": "2708",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "acne vulgaris",
        "erythema",
        "nasal decongestants",
        "oxymetazoline",
        "vasoconstriction"
    ],
    "authors": [
        "Chanudda Washrawirul",
        "Thanaporn Puaratana-arunkon",
        "Yuda Chongpison",
        "Nopadon Noppakun",
        "Pravit Asawanonda",
        "Chanat Kumtornrut"
    ],
    "citedby-count": 0,
    "ref-count": 37,
    "ref-list": [
        "Post-acne erythema treatment: a systematic review of the literature",
        "Treatment protocols and efficacy of light and laser treatments in post-acne erythema",
        "An update on the pathogenesis and management of acne vulgaris",
        "Optimal management of acne to prevent scarring and psychological sequelae",
        "Acne erythema improvement by long-pulsed 595-nm pulsed-dye laser treatment: a pilot study",
        "Easy as PIE (Postinflammatory erythema)",
        "Low-fluence 585 nm Q-switched Nd:YAG laser: a novel laser treatment for post-acne erythema",
        "Post-acne erythema successfully treated with 595-nm picosecond-domain neodymium: yttrium-aluminum-garnet laser",
        "Comparison of fractional, nonablative, 1550-nm laser and 595-nm pulsed dye laser for the treatment of facial erythema resulting from acne: a split-face, evaluator-blinded, randomized pilot study",
        "A randomized split-face, investigator-blinded study of a picosecond alexandrite laser for post-inflammatory erythema and acne scars",
        "Topical 5% tranexamic acid for acne-related postinflammatory erythema",
        "Topical brimonidine tartrate as a novel treatment for facial erythema of rosacea and acne erythema",
        "Effect of a cosmetic use with 2% isostearyl-L-ascorbic acid gel for postinflammatory hyperpigmentation and postinflammatory erythema in acne vulgaris",
        "Split-face comparative clinical trial using glyceryl-octyl-ascorbic acid/ascorbyl 2-phosphate 6-palmitate/DL-\u03b1-tocopherol phosphate complex treatment for postinflammatory hyperpigmentation, postinflammatory erythema and atrophic scar in acne vulgaris",
        "Emerging therapeutics for ocular surface disease",
        "Medical management strategies in acute and chronic rhinosinusitis",
        "Standard management options for rosacea: the 2019 update by the National Rosacea Society expert committee",
        "Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 52-week open label REVEAL trial",
        "Oxymetazoline modulates proinflammatory cytokines and the T-cell stimulatory capacity of dendritic cells",
        "Oxymetazoline inhibits proinflammatory reactions: effect on arachidonic acid-derived metabolites",
        "Oxymetazoline inhibits and resolves inflammatory reactions in human neutrophils",
        "Topical oxymetazoline hydrochloride cream 1% for the treatment of persistent facial erythema of rosacea in adults: a comprehensive review of current evidence",
        "Successful treatment of the face post acne erythema using a topically applied selective alpha 1-adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial",
        "Reliability of clinician erythema assessment grading scale",
        "An evaluation of the efficacy of a single-session 577 nm pro-yellow laser treatment in patients with postacne erythema and scarring",
        "The efficacy and safety of a 577-nm high-power optically pumped semiconductor laser in the treatment of postacne erythema",
        "Fractional photothermolysis for the treatment of postinflammatory erythema resulting from acne vulgaris",
        "Intense pulsed light therapy for acne-induced post-inflammatory erythema",
        "Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel",
        "Management of rhinitis medicamentosa: a systematic review",
        "The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors",
        "A split face comparative study using a novel triple combination therapy for the treatment of persistent post acne erythema",
        "Validated spectrofluorimetric method for the determination of oxymetazoline hydrochloride via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl)",
        "Difference in vasoconstrictors: oxymetazoline vs. brimonidine",
        "Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline",
        "Safety of topical administration of nasal decongestants and vasoconstrictors in paediatric nasal surgery\u2013a systematic review",
        "Reduction in ultraviolet B light-induced erythema by oxymetazoline and brimonidine is mediated by different \u03b1-adrenoceptors"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Medicine, Faculty of Medicine, Chulalongkorn University",
        "Division of Dermatology"
    ]
}